Infinity Pharmaceuticals Performance

Infinity Pharmaceuticals Inc -- USA Stock  

USD 1.8  0.03  1.64%

Macroaxis gives Infinity Pharmaceuticals performance score of 0 on a scale of 0 to 100. The company retains Market Volatility (i.e. Beta) of -1.1708 which attests that as returns on market increase, returns on owning Infinity Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Infinity Pharmaceuticals is expected to significantly outperform it.. Even though it is essential to pay attention to Infinity Pharmaceuticals current price history, it is always good to be careful when utilizing equity current price movements. Macroaxis philosophy towards determining future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Infinity Pharmaceuticals exposes twenty-eight different technical indicators which can help you to evaluate its performance. Infinity Pharmaceuticals has expected return of -0.1308%. Please be advised to check out Infinity Pharmaceuticals Information Ratio, Downside Variance, Day Median Price, as well as the relationship between Treynor Ratio and Kurtosis to decide if Infinity Pharmaceuticals past performance will be repeated at some point in the near future.
Investment Horizon     30 Days    Login   to change

Infinity Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  189  in Infinity Pharmaceuticals Inc on November 15, 2017 and sell it today you would lose (9)  from holding Infinity Pharmaceuticals Inc or give up 4.76% of portfolio value over 30 days. Infinity Pharmaceuticals Inc is currenly does not generate positive expected returns and assumes 4.4786% risk (volatility on return distribution) over the 30 days horizon. In different words, 41% of equities are less volatile than Infinity Pharmaceuticals Inc and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 30 days, Infinity Pharmaceuticals Inc is expected to under-perform the market. In addition to that, the company is 9.43 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.55 per unit of volatility.

Infinity Pharmaceuticals Daily Price Distribution

The median price of Infinity Pharmaceuticals for the period between Wed, Nov 15, 2017 and Fri, Dec 15, 2017 is 1.96 with a coefficient of variation of 5.3. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 1.94, and mean deviation of 0.08. The Stock received some media coverage during the period.

Risk-Adjusted Performance

Over the last 30 days Infinity Pharmaceuticals Inc has generated negative risk-adjusted returns adding no value to investors with long positions.

One Month Efficiency

Infinity Pharmaceuticals Sharpe Ratio = -0.0292
Good Returns
Average Returns
Small Returns
Negative ReturnsINFI

Estimated Market Risk

  actual daily
 59 %
of total potential

Expected Return

  actual daily
 1 %
of total potential

Risk-Adjusted Return

  actual daily
 1 %
of total potential
Based on monthly moving average Infinity Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Infinity Pharmaceuticals by adding it to a well-diversified portfolio.